Healthcare Triangle signs advance agreement for $50M acquisition of AI CX business with $34M revenue target

Healthcare Triangle, Inc.

Total consideration up to $50M: $15M cash, $6M common stock, $24M convertible preferred, $5M earnout.
Advance of $3M cash paid to Teyame; refundable if deal fails; target closing by Feb 16, 2026.
Target companies expected to generate $34M revenue and $4.2M EBITDA for FY2025.
Acquisition would combine HCTI's healthcare IT with AI omnichannel CX platforms.
Deal is non-binding and subject to definitive agreement, due diligence, and shareholder approval.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Healthcare Triangle, Inc. entered into Advance Agreement with Teyame A.I. LLC valued at up to approximately $50.0 million (effective 2025-12-05).

Action: entry
Agreement: asset purchase
Counterparty: Teyame A.I. LLC
Value: up to approximately $50.0 million
Effective: 2025-12-05

Exact text from the filing

On December 5, 2025, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”) entered into a non-binding advance agreement (the “ Advance Agreement ”) with Teyame A.I. LLC, a St. Kitts and Nevis limited liability company (“ Teyame ”), in connection with a proposed acquisition by the Company of 100% of the equity interests of Teyame 360 S.L. and Datono Mediacion S.L.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Healthcare Triangle, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-119878

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.